Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06678243 · ClinicalTrials.gov registry record · NA
Testing the mHealth App Intervention for Nondaily Smokers "SiS4"
A NA study of Smoking Cessation, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
- 1
- Study location
NCT06678243 is a NA study of Smoking Cessation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 1,600 participants, above the 466-participant average among 188 other Smoking Cessation trials with a reported enrollment target (243% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06678243, a NA study of Smoking Cessation, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to test if a new behavioral treatment for people who smoke nondaily and wish to quit works. The new treatment is a smartphone app that engages users in positive psychology exercises and gives them tested tools for quitting smoking. The positive psychology exercises help users maintain their positive emotions while they quit smoking. This app has been developed with and for people who smoke nondaily through several steps of development. The main questions it aims to answer are: * Does the smoking cessation app (SiS4) help people who smoke nondaily quit smoking? * How do people's attitudes towards smoking, their smoking urges, and their mental well-being shift when using the SiS4 app? Researchers will compare the new app to an existing app that was developed for people who smoke daily to see if the new app works better to help people who smoke nondaily quit smoking. Participants will: 1. Use a smartphone app every day for 7 weeks 2. Complete online surveys about their smoking, attitudes about smoking, withdrawal symptoms and smoking urges, app use, and mental well-being at enrollment as well as 2 weeks, 6 weeks, 3 months, 6 months and 12 months after the initially chosen quit date. If the SiS4 app works well, it would be the first evidence-based quit-smoking treatment for people who smoke nondaily.
Conditions Studied
Interventions
- BEHAVIORAL Smiling instead of Smoking
- BEHAVIORAL QuitGuide
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2024-12-06 |
| Est. Completion | 2028-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06678243
The ClinicalTrials.gov registry entry for NCT06678243 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 466-participant average among 188 other Smoking Cessation trials with a reported enrollment target (243% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Smiling instead of Smoking is the first listed.
NCT06678243 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06678243 about?
NCT06678243 is a clinical study titled "Testing the mHealth App Intervention for Nondaily Smokers "SiS4"". The goal of this project is to test if a new behavioral treatment for people who smoke nondaily and wish to quit works. The new treatment is a smartphone app that engages users in positive psychology exercises and gives them tested tools for quitting smoking. The positive psychology exercises help u...
What is the current status of trial NCT06678243?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,600 participants. The study started on 2024-12-06. Estimated completion is 2028-07-01.
What conditions does trial NCT06678243 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT06678243?
The interventions under investigation include: Smiling instead of Smoking (BEHAVIORAL), QuitGuide (BEHAVIORAL).
Who is sponsoring clinical trial NCT06678243?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06678243 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.